DON’T MISS OUT!

Unlock Actionable Insights from Bionews’ 2024 Rare Disease Survey

Gain exclusive access to practical insights tailored for pharma and advertising media agency leaders with Bionews’ 2024 Rare Disease Survey. With over 5,000 respondents, our survey offers valuable data on diagnosis, treatment experiences, and patient support.

Unmatched Reach

5,000+

Rare Disease Patient Survey Respondents

Representing

30+

Rare Disease Communities

UNLOCK RARE INSIGHTS

Sign up now to be the first to receive the results and leverage 2024 Bionews insights to drive impactful marketing strategies in the rare disease space.

Bionews privacy policy.

We Deliver: Unmatched Reach, Patient-Centric Solutions, and Impactful Partnerships

Popular Communities

NEUROLOGY

ALS
Alzheimer’s Disease
Angelman Syndrome
Batten Disease
Cerebral Palsy
Charcot-Marie-Tooth
Dravet Syndrome
Familial Amyloid Polyneuropathy
Fragile X
Friedreich’s Ataxia
Huntington’s
Multiple Sclerosis
Neuromyelitis Optica Spectrum

HEMATOLOGY

Atypical Hemolytic Uremic Syndrome
Hemophilia
Paroxysmal Nocturnal Hemoglobinuria
Sickle Cell Disease

IMMUNOLOGY &
RHEUMATOLOGY

ANCA vasculitis
Angioedema
Ankylosing Spondylitis
Cold Agglutinin
Ehlers-Danios
Epidermolysis Bullosa
Juvenile Arthritis
Lambert Eaton
Lupus
Myasthenia Gravis
Scleroderma
Sjogren’s Syndrome

ENDOCRINOLOGY
& METABOLIC

Aromatic L-amino acid decarboxylase
Cushing’s Disease
Gaucher Disease
Genetic Obesity
Hypoparathyroidism
Mitochondrial Disease
Phenylketonuria
Pompe Disease
Porphyria
XLH

Experience our commitment to delivering real-world impact for the rare disease and chronic condition community, and our partners. Connect with us at [email protected] to start a conversation today!